Product Overview
• Olmesartan medoxomil 40 mg film-coated tablets • Potent angiotensin II receptor blocker (ARB) • Once-daily treatment for essential hypertension • Prescription-only medicine • Pack contains 28 tablets (4 blister strips of 7 – 1-month supply)
Product Description
Olmepress 40 mg Tablets contain olmesartan medoxomil, a highly selective ARB that blocks angiotensin II at AT1 receptors, leading to vasodilation and reduced blood pressure without affecting heart rate. Indicated for first-line treatment of essential hypertension in adults and children ≥6 years (dose-adjusted). Provides powerful, sustained 24-hour blood pressure control with peak effect at 2–4 weeks of regular use. The 40 mg dose is the maximum recommended daily dose, used when lower doses (10 mg or 20 mg) are insufficient for adequate control. Proven to reduce cardiovascular risk and protect kidneys in hypertensive patients with diabetes. Benefits • Full 24-hour blood pressure control with single daily dose • Superior efficacy in lowering both systolic and diastolic BP • Low incidence of cough compared to ACE inhibitors • Safe in elderly, diabetic, and renal-impaired patients (with dose caution) • Proven cardiovascular protection (reduces stroke risk) and renal benefits • Once-daily dosing improves patient compliance How to Use • Adults: usual starting dose 10–20 mg once daily; titrate to 40 mg if needed (maximum 40 mg) • Elderly or hepatic/renal impairment: start at 10 mg, maximum 20 mg • Swallow whole with water – any time of day, with or without food • Can be combined with other antihypertensives (e.g., hydrochlorothiazide or amLodipine) if needed • Regular blood pressure monitoring recommended • No rebound hypertension on discontinuation